Spheres of Influence

The April issue of Environmental Health Perspectives carried an interesting article by Charles W. Schmidt,  "Nanotechnology Related Environment, Health, and Safety Research: Examining the National Strategy". The article looks at what could be a disturbing development, that

Experts in nanotoxicity and risk assessment have become increasingly polarized, represented on one side by the National Research Council (NRC) and on the other by the National Nanotechnology Initiative (NNI).

Schmidt's article notes that this polarization began after the Nanotechnology Environmental And Health Implications (NEHI) Working Group, part of NNI, released Strategy for Nanotechnology Related Environmental Health and Safety Research in February 2008. The report presented the then Bush Administration's agenda for studying nanoparticle hazards and was developed and written after "extensive consultations with regulatory agencies, research organizations, the business community and non-governmental organizations". The report reflected the concerns of the established stakeholders in nanotechnology.

In February 2009, an NRC assembled panel released its own report

. . .  describing what it calls serious short comings in the strategy document. According to the NRC panel . . . the strategy exposes weaknesses in the government's understanding of potential nanotechnology risks today and doesnot adequately address how they will be assessed in the future.

. . . NRC panelists would like to see a National Health based Strategy for nanotechnology research with defined goals, milestones, and mechanisms for assessing progress. . . . The need isn't just to insure the safety of nano-enabled products, but also to avert a public backlash against the technology, which could grow if health risks aren't seen as adequately addressed.

. . . The NNI strategy document - NRC panelists claim - is simply a compendium of federally funded projects without any unifying vision or sense of shared purpose.

An advance copy of the NRC report leaked out to the press in December 2008, leading NNI to post a rebuttal on its website , presenting the strategy document not an implementation plan, "But rather a higher-level description of the inter-agency approach to nanotechnology related EHS research."

One can only hope that the growing divide can be bridged. Both sides have much to contribute to the future growth of nanotechnology and a split into opposing camps serves neither side very well.

The final part of this article turns toward a different, in many ways more worrisome, topic. In January 2008, the EPA launched its nanoscale materials voluntary stewardship program, which urged companies to report information to EPA about their use, manufacture, import, etc of nanoparticles; according to the article, as of January 2009, only 29 companies had responded.

While companies might fear that their trade secrets might be revealed to competitors, it is more likely that what companies are afraid of are potential product liability lawsuits, legitimate or not, that would keep them in court for years (the shadow of asbestos again) and giving information to groups that would use the general public lack of understanding of nanotechnology - to most people, this is still science fiction - to create a climate of fear. At this stage in its development, the nanoindustry might be compared to the nuclear industry from 1950 until the mid-1980s. For the general public in that period, nuclear power was a mysterious thing beyond the non-scientist's ability to understand. For most people, nuclear energy meant only one thing: the power to destroy, personified in the form of Godzilla. Interest groups opposed to the further development of nuclear energy were able to use companies involved in the construction and running of nuclear power plants unwillingness to provide the public with information to create an effective climate of fear and opposition to the point where the industry nearly shut down after 3 Mile Island and Chernobyl.

To avoid this fate

. . .  nanoparticle toxicity data need to be made more widely available to insure public support for the technology.

rather than burying the information in annual reports or SEC filings, such as a 10K or a 10Q, which, while they are great sources of information, are also usually great cures for insomnia.

In an age of calls for greater transparency in both government and business, one can only hope that the nanoindustry will seize the moment and release more information in a form and language that the general public can understand. As someone once observed, sunshine is the best disinfectant.

 

 

Nanotechnology Law Report -- Spring 2009

NNI Reauthorization in Senate

The NNI Reauthorization bill is officially in the Senate, and housed in the Committee on Science Commerce and Transportation.

NNI Reauthorization in Senate

The NNI Reauthorization bill is officially in the Senate, and housed in the Committee on Science Commerce and Transportation.

NNI Reauthorization--Here we go again

Earlier today, the House of Representatives overwhelmingly passed its version of the National Nanotechnology Initiative reauthorization amendments, H.R. 554.  The passage was by "voice vote," meaning there is no record of who may have voted for or against the reauthorization.  This is the next step towards complete reauthorization of the NNI.

According to the House Science and Technology Committee: "H.R. 554 requires that the NNI agencies develop a plan for the environmental and safety research component of the program that includes explicit near-term and long-term goals, specifies the funding required to reach those goals, identifies the role of each participating agency and includes a roadmap for implementation.
... H.R. 554 also includes provisions aimed at capturing the economic benefits of nanotechnology. In 2007, $60 billion in nano-enabled products were sold; and it is predicted that the number will rise to $2.6 trillion by 2014. To encourage commercialization in the U.S.—and the corresponding economic benefit—the bill strengthens public-private partnerships by encouraging the creation of industry liaison groups to foster technology transfer and to help guide the NNI research agenda. The bill also promotes the use of nanotechnology research facilities to assist companies in the development of prototypes."

Recall that we've been down this road once before.  In the 110th House also passed the identical reauthorization language, H.R. 5490, only to have it expire at the end of the Senate's term last year.  Hopefully the Senate takes up its version of the bill more quickly this time, and completes the reauthorization process.  The companion bill has not been introduced in the Senate as yet.

NNI Reauthorization Reintroduced

Yesterday, Rep. Bart Gordon (D-TN), Chairman of the House Committee on Science and Technology introduced H.R. 554, the National Nanotechnology Initiative Amendments Act of 2009.  This is a bill identical to the 110th Congress's H.R. 5490, which passed the House by a 407 to 6 vote, but stalled in the Senate.  According to the Committee's press release the NNI Amendments Act of 2009 will "require[ ] the agencies participating in the National Nanotechnology Initiative (NNI) to develop a plan for the environmental and safety research, and a roadmap for implementing it, which includes explicit near-term and long-term goals and the funding required, by goal and by agency. The bill also seeks to leverage private sector investments in nanotechnology and facilitate technology transfer by strengthening public/private partnerships."

You'll recall that we did several posts concerning the 2008 version of the bill and the importance of reauthorizing the NNI.  While each federal agency will continue to pursue its own agenda for nanotechnology research and regulation, it s important to have an umbrella organization that is aware of all of the different efforts in order to make connections and avoid duplication when possible.  Hopefully Congress can see its way to reauthorizing the NNI before the bill expires, again.  Stay tuned for hearing announcements and bill markups.

UPDATE: NNI Bill in Senate

The saga of the status of the NNI Reauthorization Bill in the Senate, S. 3274, continues.  Remember we provided information previously about the status of reauthorization and the dangers involved in letting the legislation lapse.

The NanoBusiness Alliance is reporting that the markup for the bill is now scheduled for September, but no further information is given.  Keep an eye out for movement (hopefully) next month on NNI reauthorization legislation.

Nanotechnology Law Report -- July 2008

NNI Reauthorization Stalling in Senate

Today's lesson is: never count your chickens before they hatch.  You'll remember a few months back, the House overwhelmingly passed legislation reauthorizing the National Nanotechnology Initiative, and slightly modifying some of the work they do.  At the time, I surmised (to myself) that passage through the Senate was likely to be quick.  Perhaps not.

It turns out, the NNI re-authorization bill on the Senate side, S.3274, is getting bogged down and is in danger of not passing before the end of the term later this year.  This bill has been slow to be introduced (as in yesterday), and the Commerce, Science, and Transportation Committee may not get to consider it until next week at the earliest.

Some environmentalists are seeing this as an opportunity to try and get the 10% funding increase for EHS research back into the bill, but attempting such an effort may endanger its passage by the full Senate, which is needed to keep the NNI going.  If the full Senate doesn't pass the bill before the end of the session, the whole process will have to be restarted and approved by both chambers.  Given that a markup hasn't happened yet, passage by the end of this Congress is already looking to be tight on the calendar.  We'll have to keep an eye on the progress to see what happens between now and the end of the year. 

UPDATE: NNI Reauthorization Passed by House

We previously discussed the pending National Nanotechnology Initiative re-authorization here, and we're back today to let you know that the House of Representatives overwhelmingly passed the bill.

On June 5, the House, by a 407-6 vote, passed H.R. 5490: National Nanotechnology Initiative Amendments Act of 2008.  The bill now heads to the Senate for its consideration and vote

As reported earlier in the Committee Stage, "H.R. 5940, does not substantially alter NNI, but makes adjustments to some of the priorities of the program and strengthens one of the core components – environmental and safety research."  There was 40 minutes of debate on the House floor, upon which the motion was called for and passed by a wide margin.

My only question is: Why did the 6 Congressmen and women who voted against it, vote against it?  Unfortunately the Congressional Record for this debate is not yet available.  If you're curious who those people are, the roll-call vote is here.

House Committee Passes NNI Reauthorization

On May 7, 2008 the House Committee on Science and Technology unanimously approved H.R. 5940, the National Nanotechnology Initiative Amendments Act of 2008.  The bill now moves onto the full House, and then Senate for full consideration.  As stated by the Committee, "H.R. 5940, does not substantially alter NNI, but makes adjustments to some of the priorities of the program and strengthens one of the core components – environmental and safety research."

The full text of the bill can be found here, and we now wait to see what the full House will do with the bill.  However, the fact that H.R. 5940 is receiving bi-partisan support in committee, and was referred back to the full House so quickly (the bill was originally introduced on May 1, 2008), is positive for future action.

The National Nanotechnology Initiative Amendments Act of 2008

The House Science and Technology Committee will hear testimony on the NNI Amendments Act of 2008 on April 16, 2008.  Those scheduled to speak before the committee include:

  • Floyd Kvamme, co-chairman of the President's Council of Advisors on Science and Technology;
  • Sean Murdock, executive director of the NanoBusiness Alliance;
  • Joseph Krajcik, associate dean for research and professor of education at the University of Michigan;
  • Andrew Maynard, chief science advisor for the Woodrow Wilson Center's Project on Emerging Nanotechnologies;
  • Raymond David, manager of toxicology for the BASF Corporation;
  • Robert Doering, senior fellow and research strategy manager at Texas Instruments

This full-committee hearing will begin at 10:00 AM in 2318 Rayburn House Office Building.

Budget Numbers

The 2009 budgets for the US Environmental Protection Agency and National Nanotechnology Initiative have been released, and the numbers are interesting.  Both agencies have funds available for nano research, however note that NNI's numbers are to help that office coordinate efforts among 26 federal agencies while EPA's portion is only a small piece of the full pie. 

Key points from the $1.5 billion NNI budget include:

  • increased support for research on fundamental nanoscale phenomena and processes, from $481 million in 2007 to $551 million in 2009.
  • substantial ongoing growth in funding for instrumentation research, metrology and standards (from $53 million in 2007 to $82 million in 2009) and in nanomanufacturing research (from $48 million in 2007 to $62 million in 2009).
  • Environmental, Health, and Safety (EHS) R&D funding in 2009 ($76 million) is more than double the level of actual funding in 2005 ($35 million) - the first year this data was collected.
  • The steady growth in EHS R&D spending follows the NNI strategy of expanding the capacity to do high-quality research in this field.

Similarly, EPA's budget also provides funding for nano research and development, and in fact addresses nano in the context of the Resource Conservation Recovery Act (RCRA): "the primary objective is to determine the physicochemical properties controlling the movement of nanomaterials through soil and aquatic ecosystems. Research questions include the identification of system parameters that alter the surface characteristics of nanomaterials through aggregation (e.g. pH effects), complexation (e.g., surface complexation by dissolved organic carbon) or changes in oxidation state (e.g., chemical- or biological-mediated electron transfer)." 

EPA's total budget is $7.1 billion for fiscal year 2009, and nano-specific funding comes in at $14.9 million (or 0.21% of the total budget).  The funding is part of EPA Goal 4 of 5, "Communities and Ecosystems."

The fact that nanotechnology research funding is increasing is an encouraging sign, however, I'm concerned at the length of time it will take to complete the learning curve given the proportionally small amounts of federal investment into this increasingly important area.

Federal Nanotechnology "Roadmap"

In a strange twist of bureaucratic overkill, Congress directed EPA to contract with the National Academy of Sciences (NAS) to develop a federal strategy for researching the environmental, health, and safety risks of nanotechnology.  Did you get that?  Congress is telling EPA to tell NAS to develop the research strategy.

What makes this direction curious, included in the 2008 omnibus appropriations bill signed into law in late December, is that is appears on its face to repeat work being conducted by both EPA and the National Nanotechnology Initiative (NNI).  Congress appropriated EPA $1.9 million to contract with NAS to "develop and monitor implementation of a comprehensive, prioritized research roadmap for all federal agencies on environmental, health, and safety issues for nanotechnology."  Congress would like the contract in place by the end of March.

However, the NNI released its general strategic plan on December 31, in which it provides the broad goals and priorities of the multi-agency conglomerate.  Additionally, a second strategic plan is expected from NNI by the end of January that focuses on specifically on health and safety research.  Then, sometime in March, EPA is expected to release its nanotechnology priorities as they relate to health and environmental issues.

Finally, the NAS study was called for by a coalition of industry, trade groups, and nonprofit organizations, including the American Chemistry Council, DuPont, Environmental Defense, Dow, and the Natural Resources Defense Council.  While successfully lobbying Congress for EPA's marching orders, one unnamed coalition member defended the call for NAS involvement by saying that the NNI's work is not as "robust as what we would expect from NAS." 

This last statement may be the most telling--its not exactly a ringing endorsement of NNI's work or efforts.  Clearly the various stakeholders are unhappy with the efforts and answers being provided by NNI and EPA, or they would not have gone directly to Congress for what will be the fourth study released on strategic research priorities since December 31, 2007.  My read is that the stakeholders are getting anxious for direction from federal regulators as the continuing development of nanotechnology in the absence of information is becoming unnerving to them.  And rightfully so.  I'm concerned, however, that NNI was pushed closer to the brink of irrelevance because of the vote of no confidence from the coalition.  Between that, and the duplicative work seemingly being undertaken by no less than three organizations, I'm curious to see where we'll be when the dust all settles.  I hope the four reports do not conflict with each other, thereby adding fuel to the uncertainty fire.

NNI To Testify Before Congress (Again)

E. Clayton Teague of the National Nanotechnology Initiative is scheduled to testify before the House subcommittee on Research and Science Education on October 31 to address the NNI's development of its "risk research strategy."  NNI has been criticized by several organizations including the Project on Emerging Nanotechnologies, the American Chemistry Council, and DuPont for its delayed development of the strategy. 

The primary complaint of stakeholders is the speed at which NNI is developing its risk research priorities.  Many complain that the process is taking too long to accomplish while nanotechnology development moves further ahead.  Other comments on the program include the lack of authority over NNI member agency to dictate action, and an observation by Nanotechnology Law Report commenter Dr. Kristen Kulinowski, director of the International Council on Nanotechnology, that government could lean more heavily on non-governmental resources, including industry and research universities, for information.

The speed at which NNI is developing its risk framework is a ponderous given the concerns raised about the potential hazards or risks associated with free nanoparticles in the environment.  And the fact that the concerns over NNI's actions are being voiced by all facets of the nanotechnology community only adds to the confusion.  And, this is not the first time NNI has been questioned in this regard.  Co-author John Monica reported on prior criticism of NNI's work here, and I posted thoughts even earlier here.  Consequently, NNI's deliberate actions cannot be wholly denied.  However, we must keep in mind that NNI is undertaking a huge project in an extremely complex intersection of science, policy, and regulation.  Further NNI is tasked with overseeing the work of 26 federal agencies, none of which it has complete authority over.  Deliberate action is certainly understandable, however, at what point does the deliberateness transform into foot-dragging?  After all, this will be NNI's third appearance in front of Congress.